Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantation

被引:43
作者
Wulffraat, NM
Haas, PJ
Frosch, M
de Kleer, IM
Vogl, T
Brinkman, DMC
Quartier, P
Roth, J
Kuis, W
机构
[1] Univ Utrecht, Wilhelmina Childrens Hosp, Med Ctr, Dept Paediat Immunol, Utrecht, Netherlands
[2] Univ Munster, Dept Paediat, Munster, Germany
[3] Univ Munster, Inst Expt Dermatol, Munster, Germany
[4] Leiden Univ, Med Ctr, Dept Paediat, Leiden, Netherlands
[5] Hop Necker Enfants Malad, Dept Paediat Immunol Haematol & Rheumatol, Paris, France
关键词
D O I
10.1136/ard.62.3.236
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To determine whether myeloid related proteins (MRP8/MRP 14), a complex of two S 100 proteins related to neutrophil and monocyte activation, might be used as a marker for disease activity, and as an early indicator of relapse in juvenile idiopathic arthritis. Patients and methods: A group of 12 patients who underwent an autologous haematopoietic stem cell transplantation (ASCT) for refractory juvenile idiopathic arthritis (JIA) were studied. MRP8/MRP14 serum concentrations were determined by a sandwich enzyme linked immunosorbent assay (ELISA) as described. Improvement from baseline was described by a definition of improvement employing a core set of criteria as detailed previously by Giannini. Results: After ASCT, MRP8/MRP 14 serum concentrations in JIA showed a positive correlation with the Child Health Assessment Questionnaire (CHAQ; r = 0.80) and erythrocyte sedimentation rate (r = 0.45), but not with the total leucocyte count (r = 0.26). Mean MRP8/MRP 14 serum concentrations dropped markedly in the first three months after ASCT (p = 0.0039) and clinical parameters of disease activity such as CHAQ markedly improved (p = 0.0039). During a transient relapse there was an increase in MRP8/MRP14. Conclusions: MRP8/MRP14 serum concentration can be used as a marker for disease activity in patients who receive an ASCT for refractory JIA. This indicates a role of macrophage activation in the pathogenesis of JIA. The occurrence of MAS in three patients in this study was not preceded by significant changes in MRP8/MRP 14 concentration.
引用
收藏
页码:236 / 241
页数:6
相关论文
共 32 条
[21]   COMPLEX PATTERN OF THE MYELOMONOCYTIC DIFFERENTIATION ANTIGENS MRP8 AND MRP14 DURING CHRONIC AIRWAY INFLAMMATION [J].
ROTH, J ;
TEIGELKAMP, S ;
WILKE, M ;
GRUN, L ;
TUMMLER, B ;
SORG, C .
IMMUNOBIOLOGY, 1992, 186 (3-4) :304-314
[22]   EXPRESSION OF CALCIUM-BINDING PROTEINS MRP8 AND MRP14 IS ASSOCIATED WITH DISTINCT MONOCYTIC DIFFERENTIATION PATHWAYS IN HL-60 CELLS [J].
ROTH, J ;
GOEBELER, M ;
VANDENBOS, C ;
SORG, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 191 (02) :565-570
[23]   EXPRESSION OF THE CALCIUM-BINDING PROTEINS MRP8 AND MRP14 IN MONOCYTES IS REGULATED BY A CALCIUM-INDUCED SUPPRESSOR MECHANISM [J].
ROTH, J ;
GOEBELER, M ;
WROCKLAGE, V ;
VANDENBOS, C ;
SORG, C .
BIOCHEMICAL JOURNAL, 1994, 301 :655-660
[24]   Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate [J].
Ruperto, N ;
Ravelli, A ;
Falcini, F ;
Lepore, L ;
De Sanctis, R ;
Zulian, F ;
Buoncompagni, A ;
Sardella, ML ;
Strano, C ;
Alessio, M ;
Viola, S ;
Martini, A .
ANNALS OF THE RHEUMATIC DISEASES, 1998, 57 (01) :38-41
[26]   MEASUREMENT OF HEALTH-STATUS IN CHILDREN WITH JUVENILE RHEUMATOID-ARTHRITIS [J].
SINGH, G ;
ATHREYA, BH ;
FRIES, JF ;
GOLDSMITH, DP .
ARTHRITIS AND RHEUMATISM, 1994, 37 (12) :1761-1769
[27]  
STEPHAN JL, 1993, CLIN EXP RHEUMATOL, V11, P451
[28]  
Tyndall A, 1997, BRIT J RHEUMATOL, V36, P1
[29]   Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation [J].
Tyndall, A ;
Black, C ;
Finke, J ;
Winkler, J ;
Mertlesmann, R ;
Peter, HH ;
Gratwohl, A .
LANCET, 1997, 349 (9047) :254-254
[30]   Effectiveness and risks of total body irradiation for conditioning in the treatment of autoimmune disease with autologous bone marrow transplantation [J].
van Bekkum, DW .
RHEUMATOLOGY, 1999, 38 (08) :757-761